Harbour Trust & Investment Management Co Has $8.21 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Harbour Trust & Investment Management Co raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 14,038 shares of the healthcare conglomerate’s stock after acquiring an additional 229 shares during the quarter. Harbour Trust & Investment Management Co’s holdings in UnitedHealth Group were worth $8,208,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wealthcare Advisory Partners LLC increased its holdings in shares of UnitedHealth Group by 6.3% in the first quarter. Wealthcare Advisory Partners LLC now owns 5,512 shares of the healthcare conglomerate’s stock worth $2,727,000 after acquiring an additional 326 shares in the last quarter. Signet Financial Management LLC boosted its stake in shares of UnitedHealth Group by 8.0% during the 1st quarter. Signet Financial Management LLC now owns 725 shares of the healthcare conglomerate’s stock worth $358,000 after buying an additional 54 shares during the last quarter. 180 Wealth Advisors LLC raised its holdings in UnitedHealth Group by 40.9% during the first quarter. 180 Wealth Advisors LLC now owns 1,939 shares of the healthcare conglomerate’s stock worth $959,000 after acquiring an additional 563 shares in the last quarter. Capital Asset Advisory Services LLC increased its position in shares of UnitedHealth Group by 9.8% during the 1st quarter. Capital Asset Advisory Services LLC now owns 7,125 shares of the healthcare conglomerate’s stock worth $3,247,000 after purchasing an additional 638 shares during the last quarter. Finally, AMF Tjanstepension AB increased its holdings in UnitedHealth Group by 113.3% during the first quarter. AMF Tjanstepension AB now owns 197,274 shares of the healthcare conglomerate’s stock worth $97,618,000 after buying an additional 104,798 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 0.7 %

Shares of UnitedHealth Group stock opened at $560.82 on Friday. The company has a market cap of $517.87 billion, a P/E ratio of 36.54, a PEG ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average price is $584.16 and its 200-day moving average price is $536.49.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the firm earned $6.56 EPS. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.50%. UnitedHealth Group’s payout ratio is presently 54.72%.

Analysts Set New Price Targets

UNH has been the subject of a number of recent analyst reports. Robert W. Baird raised their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Argus increased their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Bank of America lowered their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Barclays lowered their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday. Finally, Stephens dropped their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.